The amount of macrophages, especially CD163 positive macrophages, was high in stage II CRCThe amount of CD80 positive macrophages was higher in less invasive T1 tumors & is associated with lower risk of cancer recurrenceHigher macrophage density and lower CD80/CD163 ratio were associated with impaired overall survival. This evidence concerns the gene CD163 and cancer.